MedPath

To Study The Effect Of Virechan Karma And Narikel KhandPak In Amlapitta With Special Reference To Hyperacidity

Phase 2
Conditions
Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Registration Number
CTRI/2024/07/071038
Lead Sponsor
RP Ayurvedic Hospital And Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient will be selected irrespective of gender occupation and habitat.

2.Those who are fit for virechan procedure.

3.Patients presenting with classic sign and symptoms of Amlapitta.

Exclusion Criteria

1.Age below 20 years and above 60 years.

2.Those who are not fit for Virechan procedure.

3.Patient having history of hyper acidity due to secondary underling

cause like oesophageal carcinoma.

4.Patients diagnosed with gastric and duodenal ulcer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Study The Effect Of Virechan Karma And Narikel Khand Pak In AmlapittaTimepoint: 48 days <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To Reduce the Almapitta in 48 days <br/ ><br>To study the literature related to concept of Amlapitta <br/ ><br>To study the concept of virechan karma <br/ ><br>To study the concept of Narikel khand Pak <br/ ><br>Timepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath